AR035988A1 - Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento - Google Patents

Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento

Info

Publication number
AR035988A1
AR035988A1 ARP000101995A ARP000101995A AR035988A1 AR 035988 A1 AR035988 A1 AR 035988A1 AR P000101995 A ARP000101995 A AR P000101995A AR P000101995 A ARP000101995 A AR P000101995A AR 035988 A1 AR035988 A1 AR 035988A1
Authority
AR
Argentina
Prior art keywords
preparation
quinoleina
medicinal product
derivatives
procedure
Prior art date
Application number
ARP000101995A
Other languages
English (en)
Original Assignee
Cemaf
Besins Int Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cemaf, Besins Int Lab filed Critical Cemaf
Publication of AR035988A1 publication Critical patent/AR035988A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se refiere a derivados de pirrolo[3,4-b]quinoleína de fórmula general (1), en la cual X representa un átomo de oxígeno o un átomo de azufre y A y R1 tienen su significado dado en la memoria descriptiva; un procedimiento para su preparación y el uso de dichos derivados para la preparación de un medicamento.
ARP000101995A 1999-04-27 2000-04-27 Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento AR035988A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9905302A FR2792937B1 (fr) 1999-04-27 1999-04-27 NOUVEAUX DERIVES DE PYRROLO-(3,4-b) QUINOLEINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT

Publications (1)

Publication Number Publication Date
AR035988A1 true AR035988A1 (es) 2004-08-04

Family

ID=9544900

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101995A AR035988A1 (es) 1999-04-27 2000-04-27 Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento

Country Status (13)

Country Link
US (1) US6335346B1 (es)
EP (1) EP1091959B1 (es)
JP (1) JP2002543078A (es)
CN (1) CN1182136C (es)
AR (1) AR035988A1 (es)
AT (1) ATE226582T1 (es)
DE (1) DE60000646T2 (es)
DK (1) DK1091959T3 (es)
ES (1) ES2184712T3 (es)
FR (1) FR2792937B1 (es)
PT (1) PT1091959E (es)
WO (1) WO2000064897A1 (es)
ZA (1) ZA200100165B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA72611C2 (uk) * 2000-05-17 2005-03-15 Орто-Макнейл Фармацевтикал, Інк. Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази
DE60317684D1 (de) * 2002-06-19 2008-01-03 Janssen Pharmaceutica Nv SUBSTITUIERTE 2,4-DIHYDROPYRROLOc3,4BÜCHINOLIN-9-ONDERIVATE, DIE SICH ALS PHOSPHODIESTERASEINHIBITOREN EIGNEN
FR2898358B1 (fr) * 2006-03-08 2008-05-30 Macef Sa Association d'un antagoniste du recepteur 5ht2 et d'activateur du recepteur 5ht2 par modulation allosterique et leurs utilisations comme produits medicaux
FR2912747A1 (fr) * 2007-02-19 2008-08-22 Fourtillan Snc Derives des 1-(1-hydoxy-3-oxo-propen-1-yl)-1,2,3,3a,8,8a-hexahydro- pyrrolo[2,3-b)indoles et leur utilisation en therapeutique
CN102099358B (zh) * 2008-07-29 2014-01-22 方济各安吉利克化学联合股份有限公司 具有血清素源性活性的化合物、制备它的方法和包含它的药物组合物
CN104892605A (zh) * 2015-07-06 2015-09-09 渤海大学 一种吡咯并[3,4-b]喹啉-1-酮衍生物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2023514A1 (de) * 1970-05-14 1971-12-02 Badische Anilin- & Soda-Fabrik Ag, 6700 Ludwigshafen Verfahren zur Herstellung von 5,6-gamma-Pyridonderivaten
CA1332413C (en) 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US4943579A (en) 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
EP0556585A3 (en) 1992-01-24 1993-09-01 Takeda Chemical Industries, Ltd. Condensed camptothecin derivatives their production and use as antitumor agents
IT1269862B (it) 1994-05-30 1997-04-15 Indena Spa Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono
JPH0873461A (ja) 1994-09-06 1996-03-19 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体、その製造法および抗腫瘍剤
FR2724384B1 (fr) * 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament
FR2737725B1 (fr) * 1995-08-08 1997-10-31 Valentonine Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament
IT1283635B1 (it) 1996-05-10 1998-04-23 Indena Spa Composti a scheletro camptotecinico isolati da mappia foetida e loro uso come sintoni per farmaci o come principi attivi

Also Published As

Publication number Publication date
EP1091959B1 (fr) 2002-10-23
JP2002543078A (ja) 2002-12-17
ZA200100165B (en) 2001-08-03
US6335346B1 (en) 2002-01-01
EP1091959A1 (fr) 2001-04-18
PT1091959E (pt) 2003-03-31
ATE226582T1 (de) 2002-11-15
FR2792937A1 (fr) 2000-11-03
CN1182136C (zh) 2004-12-29
FR2792937B1 (fr) 2001-08-10
CN1306532A (zh) 2001-08-01
DE60000646D1 (de) 2002-11-28
DK1091959T3 (da) 2003-02-24
DE60000646T2 (de) 2003-06-26
ES2184712T3 (es) 2003-04-16
WO2000064897A1 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
EP1783126A3 (en) N-oxides of N-phenyl-2-pyrimidine-amine derivatives
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
SV1999000118A (es) Nuevos derivados de pirazol substituidos ref. lea 33188-sv
EE201300011A (et) Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
DE60131703D1 (de) Orale feste pharmazeutische Zusammensetzungen zur pH-abhängig mehrphasigen Freisetzung
CY1105028T1 (el) Υποκατεστημενες c-ιμιδαζο-[1,2-α]πυριδιν-3-υλο-μεθυλαμινες
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
UY26370A1 (es) "imidazo-5-il-aminas bicíclicas, medicamentos que las contienen, su uso para la preparación de medicamentos y procedimiento para su preparación".
CY1105019T1 (el) Υποκατεστημενες c-ιμιδαζο-[1,2-α]πυριδιν-3-υλο-μεθυλαμινες
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
SV2006002238A (es) Inhibidores de la adenilato ciclasa soluble ref. p-sv-78. 959/gh
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
AR035988A1 (es) Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento
SE0300457D0 (sv) Novel compounds
WO2004006887A3 (en) Composition and methods for the treatment of skin disorders
ITRM20030394A1 (it) Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche.
DE60006379D1 (de) Vitamin d-analogen und ihre pharmazeutische verwendung

Legal Events

Date Code Title Description
FB Suspension of granting procedure